Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • mararie
    Junior Member
    • May 2014
    • 4

    #1

    3-year funded PhD position in Computational Biology and Systems Medicine

    Job description

    A funded 3-year PhD candidate position is available in the Computational Biology and Systems Medicine group led by Marieke Kuijjer at the Centre for Molecular Medicine Norway (NCMM), Faculty of Medicine, University of Oslo. The NCMM is a Nordic EMBL partner. For more information on our group, and to contact us (I will not routinely check this SeqAnswers post), please check https://www.kuijjerlab.org/. You can apply here: https://www.jobbnorge.no/en/availabl...tional-biology. The application deadline of this position is February 16. The recommended starting date is between Apr-Oct 2020.

    The Computational Biology and Systems Medicine group was established in 2018 and investigates how gene regulation is disrupted in cancer and other complex diseases. Our group’s research focuses on (1) developing computational tools to model gene regulation in so-called genome-wide gene regulatory networks, in specific for individual samples/patients, (2) developing algorithms that model how mutations can characterize tumors into distinct disease subtypes, (3) developing integrative methods that allow us to combine networks with other genomic data and with clinical information, (4) applying our computational tools to large-scale datasets of cancer and other complex diseases to identify new regulatory subtypes, biomarkers, and drivers of disease development and progression. See Kuijjer lab for a more detailed description of our research program.

    The candidate

    We seek a highly motivated candidate who is excited to develop new computational models and tools with applications to systems medicine. The ideal candidate is collaborative, has strong programming skills, and a sound training in applying statistics and/or machine learning to analyze large-scale biological datasets. Experience with analyzing and interpreting genomics data sets is required. Being familiar with gene regulatory processes, cancer biology, and/or biological network analysis is desirable. The selected candidate will develop computational methods to integrate gene regulatory networks with cancer mutation data and/or new approaches to analyze individual patient networks.

    Qualification requirements
    • Master’s degree in computational biology, bioinformatics, biostatistics, computer science, (bio)physics, or a related field
    • Proficient in programming and/or scripting languages, such as R, Python, MATLAB, Bash
    • Experience with analyzing and interpreting genomics data
    • Knowledge in cancer biology, gene regulation, and/or network biology is desirable
    • Professional proficiency in English
    • Willingness to work in a team environment, sharing skills and ideas, and collaborating on projects

    We offer
    • The PhD candidate position will be placed as SKO 1017 (position code) with salary NOK 479 600 – 532 300 per annum, depending on qualifications.
    • A professional, stimulating working environment
    • Attractive welfare benefits and a generous pension agreement, in addition to Oslo’s family-friendly environment with its rich opportunities for culture and outdoor activities


    How to apply

    The application must include:
    • Cover letter, stating your motivation, scientific background, and research interests
    • A detailed CV (summarizing education, positions and academic work)
    • List of reference persons: 2-3 references (name, relation to candidate, e-mail and phone number)

    The application with attachments must be submitted in English and uploaded in pdf format in our electronic recruiting system linked in the announcement. Please follow the link “apply for this job”. Applicants may be called in for an interview.

    Formal regulations

    The PhD candidate must take part in the University’s approved PhD program and is expected to complete the project within the set fellowship period. Please see the guidelines and regulations for appointments to Research Fellowships at the University of Oslo. No one can be appointed for more than one PhD Research Fellowship period at the University of Oslo. According to the Norwegian Freedom of Information Act (Offentleglova) information about the applicant may be included in the public applicant list, also in cases where the applicant has requested non-disclosure. The appointment may be shortened/given a more limited scope within the framework of the applicable guidelines on account of any previous employment in academic positions. The University of Oslo has an agreement for all employees, aiming to secure rights to research results etc. The University of Oslo aims to achieve a balanced gender composition in the workforce and to recruit people with ethnic minority backgrounds.

    About the University of Oslo

    The University of Oslo is Norway’s oldest and highest ranked educational and research institution, with 28 000 students and 7000 employees. With its broad range of academic disciplines and internationally recognised research communities, UiO is an important contributor to society. Centre for Molecular Medicine Norway (NCMM) was established in 2008 and is the Norwegian node in the Nordic EMBL Partnership for Molecular Medicine. NCMM is a joint venture between the University of Oslo, Health Region South-East and the Research Council of Norway. From 2017 NCMM is merged with the Biotechnology Centre of Oslo and now has altogether 11 research groups. The overall objective of NCMM is to conduct cutting edge research in molecular medicine and biotechnology as well as facilitate translation of discoveries in basic medical research into clinical practice.

Latest Articles

Collapse

  • SEQadmin2
    16S/ITS Profiling vs. Shotgun Metagenomics: What Changes in Your Workflow?
    by SEQadmin2




    NGS has revolutionized clinical microbiology by offering new ways to identify and surveil pathogens without prior knowledge of the target. One popular approach is 16S rRNA and ITS amplicon sequencing, which targets specific microbial markers. But studies are increasingly incorporating shotgun metagenomics, a technique that sequences all DNA from a sample without targeting specific microbial markers. This approach allows more detailed taxonomic classification, detection...
    Yesterday, 06:46 AM
  • SEQadmin2
    Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
    by SEQadmin2



    Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

    Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
    ...
    10-14-2026, 09:55 AM

ad_right_rmr

Collapse

News

Collapse

Topics Statistics Last Post
Started by SEQadmin2, 10-28-2026, 09:57 AM
0 responses
27 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-28-2026, 09:51 AM
0 responses
17 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-22-2026, 11:13 AM
0 responses
71 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-22-2026, 10:48 AM
0 responses
48 views
0 reactions
Last Post SEQadmin2  
Working...